Style | Citing Format |
---|---|
MLA | Dabaghian F, et al.. "Salvia Aristata Essential Oil: Chemical Composition, Cholinesterase Inhibition, and Neuroprotective Effects Against Oxidative Stress in Pc12 Cells." Research Journal of Pharmacognosy, vol. 12, no. 2, 2025, pp. 65-75. |
APA | Dabaghian F, Aalinezhad S, Delnavazi MR, Saeedi M, Khanavi M (2025). Salvia Aristata Essential Oil: Chemical Composition, Cholinesterase Inhibition, and Neuroprotective Effects Against Oxidative Stress in Pc12 Cells. Research Journal of Pharmacognosy, 12(2), 65-75. |
Chicago | Dabaghian F, Aalinezhad S, Delnavazi MR, Saeedi M, Khanavi M. "Salvia Aristata Essential Oil: Chemical Composition, Cholinesterase Inhibition, and Neuroprotective Effects Against Oxidative Stress in Pc12 Cells." Research Journal of Pharmacognosy 12, no. 2 (2025): 65-75. |
Harvard | Dabaghian F et al. (2025) 'Salvia Aristata Essential Oil: Chemical Composition, Cholinesterase Inhibition, and Neuroprotective Effects Against Oxidative Stress in Pc12 Cells', Research Journal of Pharmacognosy, 12(2), pp. 65-75. |
Vancouver | Dabaghian F, Aalinezhad S, Delnavazi MR, Saeedi M, Khanavi M. Salvia Aristata Essential Oil: Chemical Composition, Cholinesterase Inhibition, and Neuroprotective Effects Against Oxidative Stress in Pc12 Cells. Research Journal of Pharmacognosy. 2025;12(2):65-75. |
BibTex | @article{ author = {Dabaghian F and Aalinezhad S and Delnavazi MR and Saeedi M and Khanavi M}, title = {Salvia Aristata Essential Oil: Chemical Composition, Cholinesterase Inhibition, and Neuroprotective Effects Against Oxidative Stress in Pc12 Cells}, journal = {Research Journal of Pharmacognosy}, volume = {12}, number = {2}, pages = {65-75}, year = {2025} } |
RIS | TY - JOUR AU - Dabaghian F AU - Aalinezhad S AU - Delnavazi MR AU - Saeedi M AU - Khanavi M TI - Salvia Aristata Essential Oil: Chemical Composition, Cholinesterase Inhibition, and Neuroprotective Effects Against Oxidative Stress in Pc12 Cells JO - Research Journal of Pharmacognosy VL - 12 IS - 2 SP - 65 EP - 75 PY - 2025 ER - |